Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M23,180Revenue $M1,212Net Margin (%)-36.7Z-Score11.4
Enterprise Value $M22,379EPS $-2.0Operating Margin %-74.5F-Score4
P/E(ttm))0Cash Flow Per Share $-0.3Pre-tax Margin (%)-80.5Higher ROA y-yY
Price/Book18.810-y EBITDA Growth Rate %0Quick Ratio3.8Cash flow > EarningsY
Price/Sales22.05-y EBITDA Growth Rate %0Current Ratio3.8Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-19.2Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-32.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M236ROI % (ttm)-31.5Gross Margin Increase y-yY

Gurus Latest Trades with VRTX

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VRTXVanguard Health Care Fund 2014-03-31 Add0.13%$67.8 - $85.48
($79.08)
$ 97.7424%Add 5.89%11,628,500
VRTXGeorge Soros 2014-03-31 Buy 0.01%$67.8 - $85.48
($79.17)
$ 97.7424%New holding, 10000 sh.10,000
VRTXJohn Burbank 2014-03-31 Buy 0.01%$67.8 - $85.48
($79.17)
$ 97.7424%New holding, 2872 sh.2,872
VRTXVanguard Health Care Fund 2013-12-31 Add0.88%$60.18 - $77.83
($69.45)
$ 97.7441%Add 54.06%10,981,500
VRTXVanguard Health Care Fund 2013-09-30 Add0.29%$74.53 - $88.51
($79.62)
$ 97.7423%Add 19%7,127,997
VRTXVanguard Health Care Fund 2013-06-30 Add1.05%$52.6 - $85.6
($73.64)
$ 97.7433%Add 140.58%5,990,000
VRTXDaniel Loeb 2012-12-31 Sold Out -0.77%$38.88 - $59.42
($46.08)
$ 97.74112%Sold Out0
VRTXJohn Burbank 2012-12-31 Sold Out -0.38%$38.88 - $59.42
($46.08)
$ 97.74112%Sold Out0
VRTXDaniel Loeb 2012-09-30 Add0.22%$48.38 - $59.07
($53.5)
$ 97.7483%Add 40%700,000
VRTXJohn Burbank 2012-09-30 Reduce-0.09%$48.38 - $59.07
($53.5)
$ 97.7483%Reduce -25%150,000
VRTXGeorge Soros 2012-09-30 Sold Out -0.09%$48.38 - $59.07
($53.5)
$ 97.7483%Sold Out0
VRTXJoel Greenblatt 2012-09-30 Sold Out -0.08%$48.38 - $59.07
($53.5)
$ 97.7483%Sold Out0
VRTXDaniel Loeb 2012-06-30 Buy 0.85%$35.75 - $65.62
($50.92)
$ 97.7492%New holding, 500000 sh.500,000
VRTXJohn Burbank 2012-06-30 Buy 0.38%$35.75 - $65.62
($50.92)
$ 97.7492%New holding, 200000 sh.200,000
VRTXJoel Greenblatt 2012-06-30 Buy 0.08%$35.75 - $65.62
($50.92)
$ 97.7492%New holding, 20025 sh.20,025
VRTXJohn Hussman 2012-06-30 Sold Out -0.93%$35.75 - $65.62
($50.92)
$ 97.7492%Sold Out0
VRTXGeorge Soros 2012-06-30 Reduce-0.05%$35.75 - $65.62
($50.92)
$ 97.7492%Reduce -44%112,000
VRTXJean-Marie Eveillard 2012-06-30 Sold Out -0.02%$35.75 - $65.62
($50.92)
$ 97.7492%Sold Out0
VRTXGeorge Soros 2012-03-31 Buy 0.12%$32.2 - $42.94
($35.95)
$ 97.74172%New holding, 200000 sh.200,000
VRTXJean-Marie Eveillard 2012-03-31 Buy 0.02%$32.2 - $42.94
($35.95)
$ 97.74172%New holding, 110000 sh.110,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VRTX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
VRTX John Burbank 2014-03-312,87200.01New Buy
VRTX George Soros 2014-03-3110,00000.01New Buy
VRTX Vanguard Health Care Fund 2014-03-3111,628,5004.922.3+5.89%
Premium Most recent portfolio changes are included for Premium Members only!


VRTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Riley Wayne JosephDirector 2014-07-15Sell4,800$96.65-0.35view
Horton Kenneth LEVP & Chief Legal Officer 2014-07-01Sell30,134$95.221.14view
ULLIAN ELAINEDirector 2014-07-01Sell5,000$95.211.16view
Riley Wayne JosephDirector 2014-06-24Sell15,000$98.03-1.75view
Pace Megan ESVP, Corp. Communications 2014-06-24Sell12,734$98.03-1.75view
Sachdev AmitSVP, Global Gov. Strategy 2014-06-24Sell42,250$98.03-1.75view
MUELLER PETEREVP, Global R&D, CSO 2014-06-16Sell7,500$68.3140.99view
ULLIAN ELAINEDirector 2014-06-09Sell2,500$7528.41view
Pace Megan ESVP, Corp. Communications 2014-05-15Sell369$65.6646.68view
MUELLER PETEREVP, Global R&D, CSO 2014-05-14Sell7,500$67.4542.79view

Press Releases about VRTX :

Quarterly/Annual Reports about VRTX:

News about VRTX:

Articles On GuruFocus.com
Vanguard Health Care Fund Buys Vertex Pharmaceuticals, Zoetis Inc, , Sells Cerner Corporation, AbbVi Aug 02 2013 
Weekly Guru Bargains Highlights: MBI, VRTX, GRPN, PBI, PC Dec 16 2012 
WEEKLY CFO SELLS HIGHLIGHT: AKRX, FIO, OVRL, VRTX Oct 21 2012 
Idenix Pharmaceuticals Lagging Behind in Breakthrough Hepatitis C Drug Development Jul 13 2012 
Weekly Top Insider Sells: GMCR, VRTX, CERN, and AGN May 14 2012 
Vertex Could Climb On New Drug, VX-222 Success Apr 21 2012 
Achillion Will Surge If New Drug Is Successful Apr 21 2012 
Columbia Management Fourth Quarter Letter with Comments on SWK, AGCO, CE, MCP, VRTX, DOLE, F, HAS, A Apr 10 2012 
Was Gilead's Acquisition of Pharmasset a Dose of Bad Medicine? Mar 05 2012 
4 Pharmaceuticals with Long and Short Opportunities Feb 28 2012 


More From Other Websites
[$$] 9 Health Care Stocks From Index-Crushing Fund Jul 22 2014
Sales Tax Compliance Concerns Loom Large, But Does Automation Help? Jul 18 2014
[$$] Costly Vertex Drug Is Denied, and Medicaid Patients Sue Jul 17 2014
Biotech Stock Roundup: AbbVie Woos Shire with Revised Offer, Sarepta Slips on Eteplirsen Data Jul 16 2014
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Vertex... Jul 15 2014
INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the... Jul 15 2014
Vertex to Announce Second Quarter 2014 Financial Results on July 29 Jul 14 2014
Vertex to Announce Second Quarter 2014 Financial Results on July 29 Jul 14 2014
VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Change in Directors or Principal Officers Jul 11 2014
Vertex Announces Retirement of Peter Mueller, Ph.D. Jul 10 2014
Vertex Announces Retirement of Peter Mueller, Ph.D. Jul 10 2014
10 stocks on Jim Cramer's radar, right now Jul 09 2014
VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Entry into a Material Definitive Agreement,... Jul 09 2014
Vertex Pharmaceuticals Inc Stock Upgraded (VRTX) Jul 09 2014
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action against Vertex... Jul 07 2014
A Primer On The Hepatitis C Market Jul 03 2014
Vertex Pharmaceuticals Up on Kalydeco sNDA Submission Jul 02 2014

Add Notes, Comments or Ask Questions

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide